Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | STAT3 | P40763 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | VDR | P11473 | 1/20 | 0.41 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15941260 | 0.90 | ALDH1A1 (0.46) | GAACA12CA1CA9ALDH1A1 | |
| SCHEMBL6204944 | 0.90 | ALDH1A1 (0.46) | GAACA12CA1CA9ALDH1A1 | |
| SCHEMBL2145602 | 0.89 | CA1 (0.46) | GAACA12CA1CA9ALDH1A1 | |
| SCHEMBL241884 | 0.88 | CA1 (0.52) | GAACA12CA1CA9ALDH1A1 | |
| SCHEMBL9240104 | 0.87 | CA1 (0.45) | GAACA12CA1CA9ALDH1A1 | |
| SCHEMBL10672617 | 0.86 | CA12 (0.44) | GAACA12CA1CA9ALDH1A1 | |
| SCHEMBL3236370 | 0.86 | CA12 (0.44) | GAACA12CA1CA9ALDH1A1 | |
| SCHEMBL10670985 | 0.86 | CA12 (0.44) | GAACA12CA1CA9ALDH1A1 | |
| SCHEMBL7645036 | 0.86 | CA12 (0.44) | GAACA12CA1CA9ALDH1A1 | |
| SCHEMBL10673660 | 0.86 | CA12 (0.44) | GAACA12CA1CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 454 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4482914-A1 | REAGENTS FOR FLUORESCENT, UV, AND MS LABELING OF O-GLYCANS, AND METHODS OF MAKING AND USING THEM | Agilent Technologies, Inc. (US) | 2025-01-01 | — | — | EP | claimed |
| CN-118871547-A | Reagents for fluorescent, UV and MS labeling of O-glycans and methods of making and using the same | 安捷伦科技有限公司 | 2024-10-29 | — | — | CN | claimed |
| WO-2023164193-A1 | REAGENTS FOR FLUORESCENT, UV, AND MS LABELING OF O-GLYCANS, AND METHODS OF MAKING AND USING THEM | AGILENT TECHNOLOGIES, INC. (US) | 2023-08-31 | — | — | WO | claimed |
| CN-102168266-B | Circuit board browning liquid suitable for high-temperature halogen-free board | DONGGUAN FUMOKE CHEMICAL CO LTD | 2013-01-23 | — | — | CN | claimed |
| CN-102168266-A | Circuit board browning liquid suitable for high-temperature halogen-free board | DONGGUAN FUMOKE CHEMICAL CO LTD | 2011-08-31 | — | — | CN | claimed |
| US-20080039613-A1 | Process for the Production of Azidoalkylamines | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) | 2008-02-14 | — | — | US | claimed |
| EP-1735272-A1 | METHOD FOR PRODUCING AZIDOALKYL AMINES | Dynamit Nobel Gmbh (DE) | 2006-12-27 | — | — | EP | claimed |
| WO-2005097736-A1 | METHOD FOR PRODUCING AZIDOALKYL AMINES | DYNAMIT NOBEL GMBH (DE) | 2005-10-20 | — | — | WO | claimed |
| EP-0259849-B1 | PROCESS FOR THE PREPARATION OF C.I. VAT BLUE 16 | BASF Aktiengesellschaft (DE) | 1991-10-16 | — | — | EP | claimed |
| EP-0367944-A2 | Ether derivative of 4-[3H] -quinazolinone, a process for the preparation thereof, and pharmaceutical compositions | SPOFA spojené podniky pro zdravotnickou vyrobu (CS) | 1990-05-16 | — | — | EP | claimed |
| US-4824608-A | ALKYLATING 16,17-DIHYDROXYVIOLANTHRENE-5,10-DIONE IN TERTIARY ALIPHATIC OR CYCLOALIPHATIC AMINE AS SOLVENT | BASF AKTIENGESELLSCHAFT (DE) | 1989-04-25 | — | — | US | claimed |
| EP-0001740-B1 | PROCESS FOR THE MANUFACTURE OF 3-HALOALKOXY- AND 3-HYDROXYALKOXY-2-ALKYLPROPIONIC ACIDS ESTERS | BRACCO INDUSTRIA CHIMICA Società per Azioni (IT) | 1980-09-03 | — | — | EP | claimed |
| JP-57130975-A | — | — | None | — | — | JP | disclosed |
| JP-62281836-A | — | — | None | — | — | JP | disclosed |
| EP-4741389-A1 | KAT6 INHIBITOR | Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. (CN) | 2026-05-13 | — | — | EP | disclosed |
| US-20260055099-A1 | PROTACS FOR TARGETED DEGRADATION OF KAT2A AND KAT2B FOR THE TREATMENT OF CANCER | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2026-02-26 | — | — | US | disclosed |
| US-4258043-A | ANTIDEPRESSANTS | CASSELLA AKTIENGESELLSCHAFT (DE) | 1981-03-24 | — | — | US | disclosed |
| US-4243606-A | AZO DYE COUPLER INTERMEDIATES | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1981-01-06 | — | — | US | disclosed |
| EP-0019634-A1 | HEXAHYDRONAPHTOIMIDAZOTHIAZOLES AND PROCESS FOR PREPARING SAME | TEIJIN LIMITED (JP) | 1980-12-10 | — | — | EP | disclosed |
| US-4017622-A | BACTERICIDES | DAINIPPON PHARMACEUTICAL CO., LTD. (JA) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080039613-A1 | Process for the Production of Azidoalkylamines | UNG, ALKBH1, ALKBH2 | GAA 322/4885CA12 2410/4885CA1 3349/4885 |
| US-20260055099-A1 | PROTACS FOR TARGETED DEGRADATION OF KAT2A AND KAT2B FOR THE TREATMENT OF CANCER | KAT2A, KAT2B, KAT8 | GAA 3845/4885CA12 2297/4885CA1 1959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.